Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00595673 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007
A Phase 3 study, sponsored by Point Biomedical.
- Completed
- Registry status
- Phase 3
- Development phase
- 428
- Enrollment target
NCT00595673: Completed Phase 3 study, sponsored by Point Biomedical.
NCT00595673 is a Phase 3 study that has completed, run by Point Biomedical. The registered enrollment target is 428 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (45% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00595673, a Phase 3 study, has completed, sponsored by Point Biomedical.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 428 participants
- Enrollment target
Study Summary
This trial is to compare PB127 echocardiography to other heart imaging studies.
Interventions
- DRUG PB127 for injectable suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 428 participants |
| Start Date | 2002-07 |
| Est. Completion | 2003-10 |
| Phase | Phase 3 |
What the finished NCT00595673 record still lists
NCT00595673 is an interventional study that assigns participants to a tested intervention. The registered 428 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (45% lower).
The record links to 0 conditions, and to 1 intervention - of which PB127 for injectable suspension is the first listed.
NCT00595673 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00595673 about?
NCT00595673 is a clinical study titled "Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007". This trial is to compare PB127 echocardiography to other heart imaging studies.
What is the current status of trial NCT00595673?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 428 participants. The study started on 2002-07. Estimated completion is 2003-10.
What interventions are being tested in trial NCT00595673?
The interventions under investigation include: PB127 for injectable suspension (DRUG).
Who is sponsoring clinical trial NCT00595673?
This trial is sponsored by Point Biomedical, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00595673's enrollment target sits among peer trials
428 878th of 2000 higher than 1,121 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05566431 · 428 participants · NA
Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics
- NCT05646316 · 428 participants · Phase 3
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
- NCT05797610 · 428 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
- NCT06073626 · 428 participants · NA
Addressing Genomic Disparities in Cancer Survivors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia